Pharmacetrizine
Indications of levocetirizine
Levocetirizine dihydrochloride is indicated for the
relief of symptoms associate with the following allergic
conditions in adult:
- Seasonal allergic rhinitis
- Perennial allergic rhinitis
- Chronic idiopathic urticaria saftly and efficacy have not been
demonstrated beyond six weeks of treatment.
Pharbripril
Indication of Ramipril 2.5/5
Mild to moderate hypertension cardiac failure following myocardial
infarction to reduce proteinuria and the decline in glomerular filtration
rate in patients with diabetic nephropathy and hypertension.To reduce the
risk of myocardial infaraction,stroke or cardiovascular death and to reduce the need for revascularisation procedures in patients with an increased cardiovascular risk such as manifest coronary heart disease to reduce he
risk of myocardial infaraction,stroke or cardiovascular death in diabetic
patients.
Pharmaloratidine -5mg
Indication of Desloratidine
Seasonal allgeric rhinitis desioratadine is indicated
for the relief of the nasel and non-nasal
symptom of seasonal allgeric rhinitis
in patients 2years of age and older pernnial
allergic rhintis desloratadine is indicated for the
relief of the nasal and non-nasal symptoms of perennial
allergic rhinitis in patients 6month of age and older.
Chronic idiopathic urticaria desloratadine is indicated
for the symstomatic relief of pruritus,
reduction in the number of hives,and size of hives,
in patients with chronic idiopathic urticaria 6months
of age and older.
Pharbrinol
Indication of atenolol
Atenolol is indicated in patients with mild or
moderate hypertension and inditicated in the management
of angina pectoris.
Rosoukon 5/10
Indication of Resouvastin 5/10
- Hyperlidemia and mixed dyslipidemia
- Rosuvastatin is indicated as adjunctive therapy
to diet to reduce elevated total,Hypertriglyceridemia.
- Rosuvastatin is indicated as adjunctive therapy
to diet for the treatment of patients with hypertriglyceridemia
primary dysbtalipoproteinemia(Type all hyperlipoproteinemia)
Homozygous familial hypercholesterolema rosuvastatin is indicated as
adjunctive therapy to other liquid.
- lowering treatment (eg LDlapheresis)
primary prevention of cardiovascular.
- Reduce the risk of stroke
- Reduce the risk of myocardial infarction
- Reduce the risk of arterial revascularization procedures.